{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T23:38:09Z","timestamp":1794440289086,"version":"4.9.1"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T00:00:00Z","timestamp":1754352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T00:00:00Z","timestamp":1754352000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Good Samaritan Hospital Foundation, the John C. Erkkila, M.D. Endowment for Health and Human Performance","award":["F1237B"],"award-info":[{"award-number":["F1237B"]}]},{"name":"The OSU Biomedical Department Research Grant","award":["VMDGDR-VG78"],"award-info":[{"award-number":["VMDGDR-VG78"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-07320-y","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T08:52:40Z","timestamp":1754383960000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Phage-mediated TLR2 signaling attenuates intracellular Mycobacterium abscessus survival in macrophages"],"prefix":"10.1038","volume":"15","author":[{"given":"Hannah","family":"Kapoor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron M.","family":"Maves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeline A.","family":"Bowder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lia","family":"Danelishvili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,5]]},"reference":[{"key":"7320_CR1","doi-asserted-by":"publisher","unstructured":"Abdelaal, H. F. M., Chan, E. D., Young, L., Baldwin, S. L. & Coler, R. N. Mycobacterium abscessus: It\u2019s Complex. Microorganisms 10 https:\/\/doi.org\/10.3390\/microorganisms10071454 (2022).","DOI":"10.3390\/microorganisms10071454"},{"key":"7320_CR2","doi-asserted-by":"publisher","first-page":"e131","DOI":"10.1093\/jpids\/piy047","volume":"7","author":"GS Lamb","year":"2018","unstructured":"Lamb, G. S. & Starke, J. R. Mycobacterium abscessus infections in children: A review of current literature. J. Pediatr. Infect. Dis. Soc. 7, e131\u2013e144. https:\/\/doi.org\/10.1093\/jpids\/piy047 (2018).","journal-title":"J. Pediatr. Infect. Dis. Soc."},{"key":"7320_CR3","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/B978-0-12-818731-9.00216-0","volume":"1","author":"A Gonz\u00e1lez-Mart\u00ednez","year":"2022","unstructured":"Gonz\u00e1lez-Mart\u00ednez, A., Guti\u00e9rrez-Bautista, M. J. O. D. J. F., Reguera, J. A. & M\u00e1rquez Luis aliaga, Javier Rodr\u00edguez-Granger Mycobacterium infections. Encycl. Infect. Immun. 1, 703\u2013718. https:\/\/doi.org\/10.1016\/B978-0-12-818731-9.00216-0 (2022).","journal-title":"Encycl. Infect. Immun."},{"key":"7320_CR4","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.3389\/fmicb.2019.01977","volume":"10","author":"J Chen","year":"2019","unstructured":"Chen, J. et al. Clinical efficacy and adverse effects of antibiotics used to treat Mycobacterium abscessus pulmonary disease. Front. Microbiol. 10, 1977. https:\/\/doi.org\/10.3389\/fmicb.2019.01977 (2019).","journal-title":"Front. Microbiol."},{"key":"7320_CR5","doi-asserted-by":"publisher","unstructured":"Yang, J. H. et al. Treatment outcome in patients with Mycobacterium abscessus complex lung disease: The impact of Tigecycline and Amikacin. Antibiotics (Basel)  11 https:\/\/doi.org\/10.3390\/antibiotics11050571 (2022).","DOI":"10.3390\/antibiotics11050571"},{"key":"7320_CR6","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1093\/jac\/dkr578","volume":"67","author":"R Nessar","year":"2012","unstructured":"Nessar, R., Cambau, E., Reyrat, J. M., Murray, A. & Gicquel, B. Mycobacterium abscessus: A new antibiotic nightmare. J. Antimicrob. Chemother. 67, 810\u2013818. https:\/\/doi.org\/10.1093\/jac\/dkr578 (2012).","journal-title":"J. Antimicrob. Chemother."},{"key":"7320_CR7","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.chom.2019.01.014","volume":"25","author":"KE Kortright","year":"2019","unstructured":"Kortright, K. E., Chan, B. K., Koff, J. L. & Turner, P. E. Phage therapy: A renewed approach to combat Antibiotic-Resistant Bacteria. Cell. Host Microbe  25, 219\u2013232. https:\/\/doi.org\/10.1016\/j.chom.2019.01.014 (2019).","journal-title":"Cell. Host Microbe"},{"key":"7320_CR8","doi-asserted-by":"publisher","first-page":"162","DOI":"10.4292\/wjgpt.v8.i3.162","volume":"8","author":"DM Lin","year":"2017","unstructured":"Lin, D. M., Koskella, B. & Lin, H. C. Phage therapy: An alternative to antibiotics in the age of multi-drug resistance. World J. Gastrointest. Pharmacol. Ther. 8, 162\u2013173. https:\/\/doi.org\/10.4292\/wjgpt.v8.i3.162 (2017).","journal-title":"World J. Gastrointest. Pharmacol. Ther."},{"key":"7320_CR9","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1093\/infdis\/jiw632","volume":"215","author":"F Oechslin","year":"2017","unstructured":"Oechslin, F. et al. Synergistic interaction between phage therapy and antibiotics clears Pseudomonas aeruginosa infection in endocarditis and reduces virulence. J. Infect. Dis. 215, 703\u2013712. https:\/\/doi.org\/10.1093\/infdis\/jiw632 (2017).","journal-title":"J. Infect. Dis."},{"key":"7320_CR10","doi-asserted-by":"publisher","first-page":"e799","DOI":"10.1371\/journal.pone.0000799","volume":"2","author":"AM Comeau","year":"2007","unstructured":"Comeau, A. M., Tetart, F., Trojet, S. N., Prere, M. F. & Krisch, H. M. Phage-Antibiotic synergy (PAS): beta-lactam and quinolone antibiotics stimulate virulent phage growth. PLoS One 2, e799. https:\/\/doi.org\/10.1371\/journal.pone.0000799 (2007).","journal-title":"PLoS One"},{"key":"7320_CR11","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1128\/AEM.02850-14","volume":"81","author":"F Kamal","year":"2015","unstructured":"Kamal, F. & Dennis, J. J. Burkholderia cepacia complex phage-antibiotic synergy (PAS): Antibiotics stimulate lytic phage activity. Appl. Environ. Microbiol. 81, 1132\u20131138. https:\/\/doi.org\/10.1128\/AEM.02850-14 (2015).","journal-title":"Appl. Environ. Microbiol."},{"key":"7320_CR12","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.tim.2015.12.011","volume":"24","author":"C Torres-Barcelo","year":"2016","unstructured":"Torres-Barcelo, C. & Hochberg, M. E. Evolutionary rationale for phages as complements of antibiotics. Trends Microbiol. 24, 249\u2013256. https:\/\/doi.org\/10.1016\/j.tim.2015.12.011 (2016).","journal-title":"Trends Microbiol."},{"key":"7320_CR13","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1093\/cid\/ciac453","volume":"76","author":"RM Dedrick","year":"2023","unstructured":"Dedrick, R. M. et al. Phage therapy of mycobacterium infections: Compassionate use of phages in 20 patients with drug-resistant mycobacterial disease. Clin. Infect. Dis. 76, 103\u2013112. https:\/\/doi.org\/10.1093\/cid\/ciac453 (2023).","journal-title":"Clin. Infect. Dis."},{"key":"7320_CR14","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1186\/s13063-022-07047-5","volume":"23","author":"PD Tamma","year":"2022","unstructured":"Tamma, P. D. et al. Safety and Microbiological activity of phage therapy in persons with cystic fibrosis colonized with Pseudomonas aeruginosa: Study protocol for a phase 1b\/2, multicenter, randomized, double-blind, placebo-controlled trial. Trials 23, 1057. https:\/\/doi.org\/10.1186\/s13063-022-07047-5 (2022).","journal-title":"Trials"},{"key":"7320_CR15","doi-asserted-by":"publisher","unstructured":"Urania Rappo, M. et al. Nebulized phage therapy for patients with cystic fibrosis with chronic Pseudomonas aeruginosa pulmonary infection: A phase 1b\/2a randomized, double-blind, placebo-controlled, multicenter study. Open Forum Infect. Dis. 10, (2023). https:\/\/doi.org\/10.1093\/ofid\/ofad500.2474","DOI":"10.1093\/ofid\/ofad500.2474"},{"key":"7320_CR16","doi-asserted-by":"publisher","unstructured":"Jonczyk-Matysiak, E. et al. Phage-phagocyte interactions and their implications for phage application as therapeutics. Viruses 9 https:\/\/doi.org\/10.3390\/v9060150 (2017).","DOI":"10.3390\/v9060150"},{"key":"7320_CR17","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s10238-008-0027-8","volume":"9","author":"A Kurzepa","year":"2009","unstructured":"Kurzepa, A., Dabrowska, K., Skaradzinski, G. & Gorski, A. Bacteriophage interactions with phagocytes and their potential significance in experimental therapy. Clin. Exp. Med. 9, 93\u2013100. https:\/\/doi.org\/10.1007\/s10238-008-0027-8 (2009).","journal-title":"Clin. Exp. Med."},{"key":"7320_CR18","doi-asserted-by":"publisher","unstructured":"Carroll-Portillo, A. & Lin, H. C. Bacteriophage and the innate immune system: Access and signaling. Microorganisms 7 https:\/\/doi.org\/10.3390\/microorganisms7120625 (2019).","DOI":"10.3390\/microorganisms7120625"},{"key":"7320_CR19","doi-asserted-by":"publisher","first-page":"10771","DOI":"10.1073\/pnas.1305923110","volume":"110","author":"JJ Barr","year":"2013","unstructured":"Barr, J. J. et al. Bacteriophage adhering to mucus provide a non-host-derived immunity. Proc. Natl. Acad. Sci. U S A 110, 10771\u201310776. https:\/\/doi.org\/10.1073\/pnas.1305923110 (2013).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"7320_CR20","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/s0092-8674(02)01201-1","volume":"111","author":"S Gordon","year":"2002","unstructured":"Gordon, S. Pattern recognition receptors: Doubling up for the innate immune response. Cell 111, 927\u2013930. https:\/\/doi.org\/10.1016\/s0092-8674(02)01201-1 (2002).","journal-title":"Cell"},{"key":"7320_CR21","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1160\/TH06-12-0694","volume":"98","author":"B Opitz","year":"2007","unstructured":"Opitz, B., Hippenstiel, S., Eitel, J. & Suttorp, N. Extra- and intracellular innate immune recognition in endothelial cells. Thromb. Haemost 98, 319\u2013326 (2007).","journal-title":"Thromb. Haemost"},{"key":"7320_CR22","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/sj.cdd.4401850","volume":"13","author":"T Kawai","year":"2006","unstructured":"Kawai, T. & Akira, S. TLR signaling. Cell. Death Differ. 13, 816\u2013825. https:\/\/doi.org\/10.1038\/sj.cdd.4401850 (2006).","journal-title":"Cell. Death Differ."},{"key":"7320_CR23","doi-asserted-by":"publisher","first-page":"973","DOI":"10.15252\/emmm.201404525","volume":"7","author":"R Sartorius","year":"2015","unstructured":"Sartorius, R. et al. Antigen delivery by filamentous bacteriophage Fd displaying an anti-DEC-205 single-chain variable fragment confers adjuvanticity by triggering a TLR9-mediated immune response. EMBO Mol. Med. 7, 973\u2013988. https:\/\/doi.org\/10.15252\/emmm.201404525 (2015).","journal-title":"EMBO Mol. Med."},{"key":"7320_CR24","doi-asserted-by":"publisher","first-page":"3037","DOI":"10.4049\/jimmunol.1701745","volume":"200","author":"O Krut","year":"2018","unstructured":"Krut, O. & Bekeredjian-Ding, I. Contribution of the immune response to phage therapy. J. Immunol. 200, 3037\u20133044. https:\/\/doi.org\/10.4049\/jimmunol.1701745 (2018).","journal-title":"J. Immunol."},{"key":"7320_CR25","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.bbrc.2010.09.094","volume":"402","author":"S Hashiguchi","year":"2010","unstructured":"Hashiguchi, S., Yamaguchi, Y., Takeuchi, O., Akira, S. & Sugimura, K. Immunological basis of M13 phage vaccine: Regulation under MyD88 and TLR9 signaling. Biochem. Biophys. Res. Commun. 402, 19\u201322. https:\/\/doi.org\/10.1016\/j.bbrc.2010.09.094 (2010).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"7320_CR26","doi-asserted-by":"publisher","first-page":"8004","DOI":"10.1038\/s41598-017-08336-9","volume":"7","author":"JD Van Belleghem","year":"2017","unstructured":"Van Belleghem, J. D., Clement, F., Merabishvili, M., Lavigne, R. & Vaneechoutte, M. Pro- and anti-inflammatory responses of peripheral blood mononuclear cells induced by Staphylococcus aureus and Pseudomonas aeruginosa phages. Sci. Rep. 7, 8004. https:\/\/doi.org\/10.1038\/s41598-017-08336-9 (2017).","journal-title":"Sci. Rep."},{"key":"7320_CR27","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1006\/jmbi.1994.1582","volume":"242","author":"P Bork","year":"1994","unstructured":"Bork, P., Holm, L. & Sander, C. The Immunoglobulin fold. Structural classification, sequence patterns and common core. J. Mol. Biol. 242, 309\u2013320. https:\/\/doi.org\/10.1006\/jmbi.1994.1582 (1994).","journal-title":"J. Mol. Biol."},{"key":"7320_CR28","doi-asserted-by":"publisher","first-page":"13675","DOI":"10.1073\/pnas.1508355112","volume":"112","author":"JJ Barr","year":"2015","unstructured":"Barr, J. J. et al. Subdiffusive motion of bacteriophage in mucosal surfaces increases the frequency of bacterial encounters. Proc. Natl. Acad. Sci. U S A. 112, 13675\u201313680. https:\/\/doi.org\/10.1073\/pnas.1508355112 (2015).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"7320_CR29","doi-asserted-by":"publisher","unstructured":"Mishra, V. et al.  Possible role for bacteriophages in the treatment of SARS-CoV-2 infection. Int. J. Microbiol. 2020 8844963 https:\/\/doi.org\/10.1155\/2020\/8844963 (2020).","DOI":"10.1155\/2020\/8844963"},{"key":"7320_CR30","doi-asserted-by":"publisher","unstructured":"Shepardson, K. M. et al. Induction of antiviral immune response through recognition of the repeating subunit pattern of viral capsids is toll-like receptor 2 dependent. mBio 8. https:\/\/doi.org\/10.1128\/mBio.01356-17 (2017)","DOI":"10.1128\/mBio.01356-17"},{"key":"7320_CR31","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.3389\/fmicb.2018.01614","volume":"9","author":"L Zhang","year":"2018","unstructured":"Zhang, L. et al. Staphylococcus aureus bacteriophage suppresses LPS-Induced inflammation in MAC-T bovine mammary epithelial cells. Front. Microbiol. 9, 1614. https:\/\/doi.org\/10.3389\/fmicb.2018.01614 (2018).","journal-title":"Front. Microbiol."},{"key":"7320_CR32","doi-asserted-by":"publisher","unstructured":"Zimecki, M. et al. Effects of prophylactic administration of bacteriophages to immunosuppressed mice infected with Staphylococcus aureus  BMC Microbiol. 9 https:\/\/doi.org\/10.1186\/1471-2180-9-169 (2009).","DOI":"10.1186\/1471-2180-9-169"},{"key":"7320_CR33","doi-asserted-by":"publisher","unstructured":"Secor, P. R. et al. Filamentous bacteriophage produced by Pseudomonas aeruginosa alters the inflammatory response and promotes noninvasive infection in vivo. Infect. Immun. 85 https:\/\/doi.org\/10.1128\/IAI.00648-16 (2017).","DOI":"10.1128\/IAI.00648-16"},{"key":"7320_CR34","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.virusres.2007.09.013","volume":"131","author":"R Miedzybrodzki","year":"2008","unstructured":"Miedzybrodzki, R. et al. Bacteriophage preparation Inhibition of reactive oxygen species generation by endotoxin-stimulated polymorphonuclear leukocytes. Virus Res. 131, 233\u2013242. https:\/\/doi.org\/10.1016\/j.virusres.2007.09.013 (2008).","journal-title":"Virus Res."},{"key":"7320_CR35","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1186\/s12866-016-0889-y","volume":"16","author":"JJ Chinison","year":"2016","unstructured":"Chinison, J. J. et al. Identification of Mycobacterium avium subsp. Hominissuis secreted proteins using an in vitro system mimicking the phagosomal environment. BMC Microbiol. 16, 270. https:\/\/doi.org\/10.1186\/s12866-016-0889-y (2016).","journal-title":"BMC Microbiol."},{"key":"7320_CR36","doi-asserted-by":"publisher","first-page":"7007","DOI":"10.1038\/s41598-017-06700-3","volume":"7","author":"L Danelishvili","year":"2017","unstructured":"Danelishvili, L., Chinison, J. J. J., Pham, T., Gupta, R. & Bermudez, L. E. The voltage-dependent anion channels (VDAC) of Mycobacterium avium phagosome are associated with bacterial survival and lipid export in macrophages. Sci. Rep. 7, 7007. https:\/\/doi.org\/10.1038\/s41598-017-06700-3 (2017).","journal-title":"Sci. Rep."},{"key":"7320_CR37","doi-asserted-by":"publisher","first-page":"e29148","DOI":"10.1371\/journal.pone.0029148","volume":"6","author":"LB Davidson","year":"2011","unstructured":"Davidson, L. B., Nessar, R., Kempaiah, P., Perkins, D. J. & Byrd, T. F. Mycobacterium abscessus glycopeptidolipid prevents respiratory epithelial TLR2 signaling as measured by HbetaD2 gene expression and IL-8 release. PLoS One  6, e29148. https:\/\/doi.org\/10.1371\/journal.pone.0029148 (2011).","journal-title":"PLoS One"},{"key":"7320_CR38","doi-asserted-by":"publisher","first-page":"e1008294","DOI":"10.1371\/journal.ppat.1008294","volume":"16","author":"BR Kim","year":"2020","unstructured":"Kim, B. R., Kim, B. J., Kook, Y. H. & Kim, B. J. Mycobacterium abscessus infection leads to enhanced production of type 1 interferon and NLRP3 inflammasome activation in murine macrophages via mitochondrial oxidative stress. PLoS Pathog. 16, e1008294. https:\/\/doi.org\/10.1371\/journal.ppat.1008294 (2020).","journal-title":"PLoS Pathog"},{"key":"7320_CR39","doi-asserted-by":"publisher","unstructured":"Bernut, A. et al. CFTR protects against Mycobacterium abscessus infection by fine-tuning host oxidative defenses. Cell Rep. 26, 1828\u20131840 e1824. https:\/\/doi.org\/10.1016\/j.celrep.2019.01.071 (2019)","DOI":"10.1016\/j.celrep.2019.01.071"},{"key":"7320_CR40","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1182\/blood.v98.3.743","volume":"98","author":"E Ayroldi","year":"2001","unstructured":"Ayroldi, E. et al. Modulation of T-cell activation by the glucocorticoid-induced leucine zipper factor via Inhibition of nuclear factor kappab. Blood 98, 743\u2013753. https:\/\/doi.org\/10.1182\/blood.v98.3.743 (2001).","journal-title":"Blood"},{"key":"7320_CR41","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.3201\/2109.141634","volume":"21","author":"MR Lee","year":"2015","unstructured":"Lee, M. R. et al. Mycobacterium abscessus complex infections in humans. Emerg. Infect. Dis. 21, 1638\u20131646. https:\/\/doi.org\/10.3201\/2109.141634 (2015).","journal-title":"Emerg. Infect. Dis."},{"key":"7320_CR42","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1007\/s12275-011-1512-4","volume":"49","author":"BR Tiwari","year":"2011","unstructured":"Tiwari, B. R., Kim, S., Rahman, M. & Kim, J. Antibacterial efficacy of lytic Pseudomonas bacteriophage in normal and neutropenic mice models. J. Microbiol. 49, 994\u2013999. https:\/\/doi.org\/10.1007\/s12275-011-1512-4 (2011).","journal-title":"J. Microbiol."},{"key":"7320_CR43","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.jtbi.2017.06.037","volume":"429","author":"CYJ Leung","year":"2017","unstructured":"Leung, C. Y. J. & Weitz, J. S. Modeling the synergistic elimination of bacteria by phage and the innate immune system. J. Theor. Biol. 429, 241\u2013252. https:\/\/doi.org\/10.1016\/j.jtbi.2017.06.037 (2017).","journal-title":"J. Theor. Biol."},{"key":"7320_CR44","doi-asserted-by":"publisher","unstructured":"Roach, D. R. et al. Synergy between the host immune system and bacteriophage is essential for successful phage therapy against an acute respiratory pathogen. Cell Host Microbe 22, 38\u201347 e34. https:\/\/doi.org\/10.1016\/j.chom.2017.06.018 (2017).","DOI":"10.1016\/j.chom.2017.06.018"},{"key":"7320_CR45","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/1471-2180-11-195","volume":"11","author":"VD Paul","year":"2011","unstructured":"Paul, V. D. et al. Lysis-deficient phages as novel therapeutic agents for controlling bacterial infection. BMC Microbiol. 11, 195. https:\/\/doi.org\/10.1186\/1471-2180-11-195 (2011).","journal-title":"BMC Microbiol."},{"key":"7320_CR46","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1093\/jac\/dki177","volume":"56","author":"N Mushtaq","year":"2005","unstructured":"Mushtaq, N., Redpath, M. B., Luzio, J. P. & Taylor, P. W. Treatment of experimental Escherichia coli infection with recombinant bacteriophage-derived capsule depolymerase. J. Antimicrob. Chemother. 56, 160\u2013165. https:\/\/doi.org\/10.1093\/jac\/dki177 (2005).","journal-title":"J. Antimicrob. Chemother."},{"key":"7320_CR47","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.3389\/fmicb.2017.02257","volume":"8","author":"H Lin","year":"2017","unstructured":"Lin, H., Paff, M. L., Molineux, I. J. & Bull, J. J. Therapeutic application of phage capsule depolymerases against K1, K5, and K30 capsulated E. coli in mice. Front. Microbiol. 8, 2257. https:\/\/doi.org\/10.3389\/fmicb.2017.02257 (2017).","journal-title":"Front. Microbiol."},{"key":"7320_CR48","doi-asserted-by":"publisher","unstructured":"Lin, H., Paff, M. L., Molineux, I. J. & Bull, J. J. Antibiotic therapy using phage depolymerases: robustness across a range of conditions. Viruses 10. https:\/\/doi.org\/10.3390\/v10110622 (2018)","DOI":"10.3390\/v10110622"},{"key":"7320_CR49","doi-asserted-by":"publisher","first-page":"738070","DOI":"10.3389\/fimmu.2021.738070","volume":"12","author":"JH Ahn","year":"2021","unstructured":"Ahn, J. H. et al. Type I interferons are involved in the intracellular growth control of Mycobacterium abscessus by mediating NOD2-Induced production of nitric oxide in macrophages. Front. Immunol. 12, 738070. https:\/\/doi.org\/10.3389\/fimmu.2021.738070 (2021).","journal-title":"Front. Immunol."},{"key":"7320_CR50","doi-asserted-by":"publisher","first-page":"acmi000154","DOI":"10.1099\/acmi.0.000154","volume":"2","author":"K Bogdanovski","year":"2020","unstructured":"Bogdanovski, K. et al. Antibacterial activity of high-dose nitric oxide against pulmonary Mycobacterium abscessus disease. Access. Microbiol. 2, acmi000154. https:\/\/doi.org\/10.1099\/acmi.0.000154 (2020).","journal-title":"Access. Microbiol."},{"key":"7320_CR51","doi-asserted-by":"publisher","unstructured":"Goldbart, A. & Gatt, D. Golan tripto, I. Non-nuberculous mycobacteria infection treated with intermittently inhaled high-dose nitric oxide. BMJ Case Rep. 14 https:\/\/doi.org\/10.1136\/bcr-2021-243979 (2021).","DOI":"10.1136\/bcr-2021-243979"},{"key":"7320_CR52","doi-asserted-by":"publisher","unstructured":"Chau, T. et al. High efficacy of High-dose nitric oxide and its synergistic effect with antibiotics against Mycobacterium abscessus. Eur. Respir J. 54 https:\/\/doi.org\/10.1183\/13993003.congress-2019.OA4950 (2019).","DOI":"10.1183\/13993003.congress-2019.OA4950"},{"key":"7320_CR53","doi-asserted-by":"publisher","unstructured":"Ghaffari, A., da Silva, J. L., Bogdanovski, K., Zelazny, A. M. & Olivier, K. N. High-dose nitric oxide as a potential new therapeutic agent against Mycobacterium abscessus. Eur. Respir J. 52 https:\/\/doi.org\/10.1183\/13993003.congress-2018.PA5463 (2018).","DOI":"10.1183\/13993003.congress-2018.PA5463"},{"key":"7320_CR54","doi-asserted-by":"publisher","first-page":"e3002341","DOI":"10.1371\/journal.pbio.3002341","volume":"21","author":"MC Bichet","year":"2023","unstructured":"Bichet, M. C. et al. Mammalian cells internalize bacteriophages and use them as a resource to enhance cellular growth and survival. PLoS Biol. 21, e3002341. https:\/\/doi.org\/10.1371\/journal.pbio.3002341 (2023).","journal-title":"PLoS Biol."},{"key":"7320_CR55","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.tube.2005.08.021","volume":"85","author":"B Ryffel","year":"2005","unstructured":"Ryffel, B. et al. Innate immunity to mycobacterial infection in mice: Critical role for toll-like receptors. Tuberculosis (Edinb)  85, 395\u2013405. https:\/\/doi.org\/10.1016\/j.tube.2005.08.021 (2005).","journal-title":"Tuberculosis (Edinb)"},{"key":"7320_CR56","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1128\/IAI.02853-14","volume":"83","author":"JS Kim","year":"2015","unstructured":"Kim, J. S. et al. Essential engagement of toll-like receptor 2 in initiation of early protective Th1 response against rough variants of Mycobacterium abscessus. Infect. Immun. 83, 1556\u20131567. https:\/\/doi.org\/10.1128\/IAI.02853-14 (2015).","journal-title":"Infect. Immun."},{"key":"7320_CR57","doi-asserted-by":"publisher","first-page":"432","DOI":"10.3389\/fcimb.2020.00432","volume":"10","author":"V Le Moigne","year":"2020","unstructured":"Le Moigne, V. et al. A TLR2-activating fraction from rough variant demonstrates vaccine and diagnostic potential. Front. Cell. Infect. Microbiol. 10, 432. https:\/\/doi.org\/10.3389\/fcimb.2020.00432 (2020).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"7320_CR58","doi-asserted-by":"publisher","unstructured":"Hu, W. & Spaink, H. P. The role of TLR2 in infectious diseases caused by mycobacteria: From cell biology to therapeutic target. Biology (Basel) 11 https:\/\/doi.org\/10.3390\/biology11020246 (2022).","DOI":"10.3390\/biology11020246"},{"key":"7320_CR59","doi-asserted-by":"publisher","first-page":"e40","DOI":"10.4110\/in.2021.21.e40","volume":"21","author":"EJ Park","year":"2021","unstructured":"Park, E. J., Silwal, P. & Jo, E. K. Host-Pathogen interactions operative during Mycobacteroides abscessus infection. Immune Netw. 21, e40. https:\/\/doi.org\/10.4110\/in.2021.21.e40 (2021).","journal-title":"Immune Netw."},{"key":"7320_CR60","doi-asserted-by":"publisher","first-page":"910","DOI":"10.4049\/jimmunol.167.2.910","volume":"167","author":"EH Noss","year":"2001","unstructured":"Noss, E. H. et al. Toll-like receptor 2-dependent Inhibition of macrophage class II MHC expression and antigen processing by 19-kDa lipoprotein of Mycobacterium tuberculosis. J. Immunol. 167, 910\u2013918. https:\/\/doi.org\/10.4049\/jimmunol.167.2.910 (2001).","journal-title":"J. Immunol."},{"key":"7320_CR61","doi-asserted-by":"publisher","first-page":"29880","DOI":"10.1074\/jbc.M303446200","volume":"278","author":"M Gilleron","year":"2003","unstructured":"Gilleron, M., Quesniaux, V. F. & Puzo, G. Acylation state of the phosphatidylinositol hexamannosides from Mycobacterium bovis Bacillus calmette Guerin and Mycobacterium tuberculosis H37Rv and its implication in toll-like receptor response. J. Biol. Chem. 278, 29880\u201329889. https:\/\/doi.org\/10.1074\/jbc.M303446200 (2003).","journal-title":"J. Biol. Chem."},{"key":"7320_CR62","doi-asserted-by":"publisher","first-page":"33419","DOI":"10.1074\/jbc.274.47.33419","volume":"274","author":"E Lien","year":"1999","unstructured":"Lien, E. et al. Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products. J. Biol. Chem. 274, 33419\u201333425. https:\/\/doi.org\/10.1074\/jbc.274.47.33419 (1999).","journal-title":"J. Biol. Chem."},{"key":"7320_CR63","doi-asserted-by":"publisher","first-page":"20961","DOI":"10.1074\/jbc.M411379200","volume":"280","author":"Y Bulut","year":"2005","unstructured":"Bulut, Y. et al. Mycobacterium tuberculosis heat shock proteins use diverse toll-like receptor pathways to activate pro-inflammatory signals. J. Biol. Chem. 280, 20961\u201320967. https:\/\/doi.org\/10.1074\/jbc.M411379200 (2005).","journal-title":"J. Biol. Chem."},{"key":"7320_CR64","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1111\/j.1462-5822.2007.00914.x","volume":"9","author":"EK Jo","year":"2007","unstructured":"Jo, E. K., Yang, C. S., Choi, C. H. & Harding, C. V. Intracellular signalling cascades regulating innate immune responses to mycobacteria: Branching out from toll-like receptors. Cell. Microbiol. 9, 1087\u20131098. https:\/\/doi.org\/10.1111\/j.1462-5822.2007.00914.x (2007).","journal-title":"Cell. Microbiol."},{"key":"7320_CR65","doi-asserted-by":"publisher","first-page":"104842","DOI":"10.1016\/j.phrs.2020.104842","volume":"158","author":"JP Vago","year":"2020","unstructured":"Vago, J. P. et al. Glucocorticoid-induced leucine zipper modulates macrophage polarization and apoptotic cell clearance. Pharmacol. Res. 158, 104842. https:\/\/doi.org\/10.1016\/j.phrs.2020.104842 (2020).","journal-title":"Pharmacol. Res."},{"key":"7320_CR66","doi-asserted-by":"publisher","first-page":"3111","DOI":"10.3389\/fimmu.2018.03111","volume":"9","author":"J Hoppstadter","year":"2018","unstructured":"Hoppstadter, J. et al. Amplified host defense by toll-like receptor-mediated downregulation of the glucocorticoid-induced leucine zipper (GILZ) in macrophages. Front. Immunol. 9, 3111. https:\/\/doi.org\/10.3389\/fimmu.2018.03111 (2018).","journal-title":"Front. Immunol."},{"key":"7320_CR67","doi-asserted-by":"publisher","unstructured":"Ricci, E. et al. Glucocorticoid-Induced leucine Zipper-Mediated TLR2 downregulation accounts for reduced neutrophil activity following acute DEX treatment. Cells 10 https:\/\/doi.org\/10.3390\/cells10092228 (2021).","DOI":"10.3390\/cells10092228"},{"key":"7320_CR68","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1002\/JLB.3AB0718-255R","volume":"105","author":"E Ricci","year":"2019","unstructured":"Ricci, E. et al. GILZ restrains neutrophil activation by inhibiting the MAPK pathway. J. Leukoc. Biol. 105, 187\u2013194. https:\/\/doi.org\/10.1002\/JLB.3AB0718-255R (2019).","journal-title":"J. Leukoc. Biol."},{"key":"7320_CR69","doi-asserted-by":"publisher","first-page":"13004","DOI":"10.1038\/srep13004","volume":"5","author":"F Gao","year":"2015","unstructured":"Gao, F. et al. A critical role of toll-like receptor 2 (TLR2) and its\u2019 in vivo ligands in radio-resistance. Sci. Rep. 5, 13004. https:\/\/doi.org\/10.1038\/srep13004 (2015).","journal-title":"Sci. Rep."},{"key":"7320_CR70","doi-asserted-by":"publisher","first-page":"e0117977","DOI":"10.1371\/journal.pone.0117977","volume":"10","author":"M Gatto","year":"2015","unstructured":"Gatto, M. et al. The involvement of TLR2 and TLR4 in cytokine and nitric oxide production in visceral leishmaniasis patients before and after treatment with anti-leishmanial drugs. PLoS One. 10, e0117977. https:\/\/doi.org\/10.1371\/journal.pone.0117977 (2015).","journal-title":"PLoS One"},{"key":"7320_CR71","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1007\/s00705-016-2904-x","volume":"161","author":"MS Abdul-Cader","year":"2016","unstructured":"Abdul-Cader, M. S., Amarasinghe, A. & Abdul-Careem, M. F. Activation of toll-like receptor signaling pathways leading to nitric oxide-mediated antiviral responses. Arch. Virol. 161, 2075\u20132086. https:\/\/doi.org\/10.1007\/s00705-016-2904-x (2016).","journal-title":"Arch. Virol."},{"key":"7320_CR72","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1111\/j.1399-302X.2008.00432.x","volume":"23","author":"LG Marcato","year":"2008","unstructured":"Marcato, L. G. et al. The role of Toll-like receptors 2 and 4 on reactive oxygen species and nitric oxide production by macrophage cells stimulated with root canal pathogens. Oral Microbiol. Immunol. 23, 353\u2013359. https:\/\/doi.org\/10.1111\/j.1399-302X.2008.00432.x (2008).","journal-title":"Oral Microbiol. Immunol."},{"key":"7320_CR73","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.bjid.2015.10.011","volume":"20","author":"S Mukherjee","year":"2016","unstructured":"Mukherjee, S., Karmakar, S. & Babu, S. P. TLR2 and TLR4 mediated host immune responses in major infectious diseases: A review. Braz J. Infect. Dis. 20, 193\u2013204. https:\/\/doi.org\/10.1016\/j.bjid.2015.10.011 (2016).","journal-title":"Braz J. Infect. Dis."},{"key":"7320_CR74","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/0076-6879(91)04027-l","volume":"204","author":"WR Jacobs Jr","year":"1991","unstructured":"Jacobs, W. R. Jr. et al. Genetic systems for mycobacteria. Methods Enzymol. 204, 537\u2013555. https:\/\/doi.org\/10.1016\/0076-6879(91)04027-l (1991).","journal-title":"Methods Enzymol."},{"key":"7320_CR75","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s12575-009-9008-x","volume":"11","author":"HP Erickson","year":"2009","unstructured":"Erickson, H. P. Size and shape of protein molecules at the nanometer level determined by sedimentation, gel filtration, and electron microscopy. Biol. Proced. Online. 11, 32\u201351. https:\/\/doi.org\/10.1007\/s12575-009-9008-x (2009).","journal-title":"Biol. Proced. Online"},{"key":"7320_CR76","doi-asserted-by":"publisher","unstructured":"Gorzynski, M., De Ville, K., Week, T., Jaramillo, T. & Danelishvili, L. Understanding the phage-host interaction mechanism toward improving the efficacy of current antibiotics in Mycobacterium abscessus. Biomedicines 11 https:\/\/doi.org\/10.3390\/biomedicines11051379 (2023).","DOI":"10.3390\/biomedicines11051379"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-07320-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-07320-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-07320-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T18:34:05Z","timestamp":1757356445000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-07320-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,5]]},"references-count":76,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7320"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-07320-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,5]]},"assertion":[{"value":"30 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"28504"}}